Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
Price Target
Average
54.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
68.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Soleno Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SLNO of $72.2 , with forecasts ranging from
a
low of
$59 to a high of $93 .
SLNO Lowest Price Target
Wall Street Target
59 USD
25.91%
SLNO Average Price Target
Wall Street Target
72.2 USD
54.00%
SLNO Highest Price Target
Wall Street Target
93 USD
98.46%
REVENUE FORECAST
Revenue Forecast Chart SLNO
EBIT FORECAST
EBIT Forecast Chart SLNO
NET INCOME FORECAST
Net Income Chart SLNO